ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VLG Venture Life Group Plc

38.25
0.05 (0.13%)
Last Updated: 08:00:08
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Venture Life Group Plc LSE:VLG London Ordinary Share GB00BFPM8908 ORD 0.3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 0.13% 38.25 38.00 38.50 38.25 38.25 38.25 27,379 08:00:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Misc Retail Stores, Nec 51.41M 921k 0.0072 53.13 48.53M
Venture Life Group Plc is listed in the Misc Retail Stores sector of the London Stock Exchange with ticker VLG. The last closing price for Venture Life was 38.20p. Over the last year, Venture Life shares have traded in a share price range of 32.00p to 49.50p.

Venture Life currently has 127,052,312 shares in issue. The market capitalisation of Venture Life is £48.53 million. Venture Life has a price to earnings ratio (PE ratio) of 53.13.

Venture Life Share Discussion Threads

Showing 36626 to 36649 of 36850 messages
Chat Pages: 1474  1473  1472  1471  1470  1469  1468  1467  1466  1465  1464  1463  Older
DateSubjectAuthorDiscuss
01/2/2024
15:19
(I picked up just a few earlier...
...& seeing the spike above 40p I couldn't resist doubling up, ... probably/might fall from the spike now !)

smithie6
01/2/2024
15:10
This is in far better shape than it was last year or even the year before and the share-price should eventually reflect that!

Debt dropping fast, sales accelerating and excellent cash conversion.

There looks to be more good news to filter through due to the increase in margin and further listings and launches which occurred late on in 2023. I think 2024 forecasts could well be upgraded through the year.

thedudie
01/2/2024
15:03
Boom, there we go....
qs99
01/2/2024
14:48
40p on the offer, should see the back of it I reckon today, DYOR
qs99
01/2/2024
14:47
Great update.. I've monitored Amazon numbers myself and kept an eye on Gelclair which is growing really well... Onwards and upwards..
celeritas
01/2/2024
14:27
..did he warn about AGFX...or he kept singing it's praises?

I had thought it was the second.

smithie6
01/2/2024
13:06
Smithie6,
I'm very happy with all Brummy Git coverage.
Some of his interviews get the alarm bells ringing.
Thanks to his interview last July I sold out of AGFX, so no complaints here.

eagle eye
01/2/2024
12:24
Out with profit & going to reinvest in APH (alliance Pharma )
blackhorse23
01/2/2024
12:17
Now up over 10% on over 750k shares traded, so hopefully any sellers are being squeezed out.

Cavendish summarise in today's note as follows:

"Delivering organically

Venture Life Group has released a positive trading update, with revenues expected to be in-line with our forecasts at £51m +16% YoY and a c2ppts uplift in EBITDA margin. FY23E revenue growth was delivered completely organically, a first since 2019, in-line with the company’s near-term focus on organic growth. Significantly, cash from operations increased over 70% to c£9.5m (in-line with expectations) supporting our analysis of free cash generation and yield. Cash generation also supported a reduction in group net leverage, which was 1.25x at December 2023 versus 1.65x at the close of 2022. Looking forward, Venture Life aims to build on its momentum through targeted investment in sales and marketing to position the group for sustained future growth and profitability."

And:

"Cash – The group delivered strong cash from operations, generating c£9.5m (Cavendish est. £9.5m), up over 70% YoY. This cash flow has helped further lower group net leverage to 1.25x at year-end 2023 versus 1.65x as of December 2022. The company notes further improvement to c1.1x post period end.

- Operational – Management has seen encouraging sales from newly developed products, noting improved sales volumes supported by price increases through H2/23A, which will clearly be supportive into FY24E. The company’s digital transformation strategy delivered online sales growth +40% to £3.8m for the year (H1/23 £1.6m). Through the year 28 new listings were achieved across UK retailers, which will further support our FY24E revenue growth expectations."

rivaldo
01/2/2024
11:16
Eagle eye

Ask Brummy Git about how the Vox coverage 'worked' for Argentex !!

;-)

smithie6
01/2/2024
10:00
You'd have though a P/E of at least 8 on 2023 would be achievable, giving a share price of 43p, rising to 51p if they hit their 2024 numbers...
stemis
01/2/2024
08:46
Have bought some more this am.
qs99
01/2/2024
08:22
Brummy_git,
You have just beaten me to it.
Micro Caps definitely benefit from Vox coverage.
Thank you!

eagle eye
01/2/2024
08:17
In this upbeat interview, CEO Jerry Randall of consumer healthcare products firm Venture Life, takes me through today's in line yearend trading update & positive outlook for 2024.
brummy_git
01/2/2024
08:15
Solid update IMO, debt falling very nicely, may be able to see some more M&A therefore over the coming years DYOR..should see back of 40 then 50p IMO
qs99
01/2/2024
08:07
We deserve a relief rally because i was very twitchy prior to this update!
rimau1
01/2/2024
07:51
Solid. Let's get over 40p for a start
bagpuss67
01/2/2024
07:45
Should be debt free FY24 and generating strong FCF. looking forward to results in April and to see how VLG see themselves evolving organically, room for a small bolt on or two.
rimau1
01/2/2024
07:35
Finncap have reiterated their 68p target price and their forecasts of 5.4p EPS for last year, rising to 6.4p EPS this year.

Net debt is due to fall to a mere £5.3m at the end of this year (from £16.6m at the end of 2022).

Which puts VLG on a current year P/E of just 5.3.

rivaldo
01/2/2024
07:20
Excellent - a solid trading update in line with expectations, and with no hiccups whatsoever:

- cash coversion and net debt both improving nicely
- own brands revenues growing well organically and now 59% of total revenues
- margins up and benefit of price increases still to come
- and a strong, confident outlook:

"Benefiting from our robust growth, clear strategic priorities aimed at refining our operation, substantial generation of free cashflow and a strong balance sheet, we are now in a prime position to deliver strong shareholder returns"

Time for a re-rating.

rivaldo
01/2/2024
07:19
There's been an 'in line' trading update from consumer healthcare products firm Venture Life today.

All the details here.

brummy_git
31/1/2024
17:24
I said it, it's the unexpected hanging paradox. :)
mjneish
31/1/2024
16:55
They indicated January hope this is not bad news being held back. Maybe tomorrow but that's Feb
chester9
31/1/2024
14:51
Maybe celeritas! But every schoolboy knows tomorrow never comes!
deanowls
Chat Pages: 1474  1473  1472  1471  1470  1469  1468  1467  1466  1465  1464  1463  Older

Your Recent History

Delayed Upgrade Clock